Annals of the New York Academy of Sciences

Cover image for Annals of the New York Academy of Sciences

August 1997

Volume 823 Neuropsychiatric Manifestations of Systemic Lupus Erythematosis

Pages ix–x, 1–333

  1. Preface

    1. Top of page
    2. Preface
    3. Part I. Stress, Stroke, and Seizures
    4. Part II. Cerebrovascular Disease in Systemic Lupus Erythematosus
    5. Part III. Neuroendocrine Aspects of Systemic Lupus Erythematosus
    6. Part IV. Autoantibodies and Systemic Lupus Erythematosus
    7. Part V. Planning Studies
    1. You have free access to this content
      Preface (pages ix–x)

      Patricia M. Moore

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1997.tb48375.x

  2. Part I. Stress, Stroke, and Seizures

    1. Top of page
    2. Preface
    3. Part I. Stress, Stroke, and Seizures
    4. Part II. Cerebrovascular Disease in Systemic Lupus Erythematosus
    5. Part III. Neuroendocrine Aspects of Systemic Lupus Erythematosus
    6. Part IV. Autoantibodies and Systemic Lupus Erythematosus
    7. Part V. Planning Studies
    1. Evaluating the Neurocognitive Complications of SLE Lessons from HIV Disease (pages 18–43)

      IGOR GRANT, ROBERT K. HEATON and THOMAS D. MARCOTTE

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1997.tb48377.x

    2. Cognition and Mood in Systemic Lupus Erythematosu : Evaluation and Pathogenesis (pages 44–59)

      SUSAN D. DENBURG, RAMONA M. CARBOTTE and JUDAH A. DENBURG

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1997.tb48378.x

    3. Cognitive Disorders in Systemic Lupus Erythematosus : Epidemiologic and Clinical Issues (pages 60–68)

      JOHN G. HANLY and MATTHEW H. LIANG

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1997.tb48379.x

    4. Psychiatric and Neurocognitive Concomitants of Systemic Lupus Erythematosus (pages 69–80)

      P. A. KEENAN and JAMES CONWAY

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1997.tb48380.x

    5. Glucocorticoid Medication, Memory and Steroid Psychosis in Medical Illness (pages 81–96)

      OWEN M. WOLKOWITZ, VICTOR I. REUS, JONATHAN CANICK, BRONSON LEVIN and SONIA LUPIEN

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1997.tb48381.x

    6. Animal Models for Nervous System Disease in Systemic Lupus Erythematosus (pages 97–106)

      ROBIN L. BREY, BORIS SAKIC, HENRY SZECHTMAN and JUDAH A. DENBURG

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1997.tb48382.x

    7. Memory, Learning Ability, and Neuropathologic Status of Mice with Systemic Lupus Erythematosus (pages 107–115)

      SARA E. WALKER, DENNIS C. WRIGHT, FRANK X. O'SULLIVAN, GAYLE C. JOHNSON, CYNTHIA L. BESCH-WILLIFORD and CATHERINE M. VOGELWEID

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1997.tb48383.x

    8. Selected Poster Paper

  3. Part II. Cerebrovascular Disease in Systemic Lupus Erythematosus

    1. Top of page
    2. Preface
    3. Part I. Stress, Stroke, and Seizures
    4. Part II. Cerebrovascular Disease in Systemic Lupus Erythematosus
    5. Part III. Neuroendocrine Aspects of Systemic Lupus Erythematosus
    6. Part IV. Autoantibodies and Systemic Lupus Erythematosus
    7. Part V. Planning Studies
    1. Detection of Cerebral Ischemia in Systemic Lupus Erythematosus by Magnetic Resonance Techniques (pages 120–131)

      K. M. A. WELCH, VIJAYA NAGESH, MICHAEL BOSKA and PATRICIA M. MOORE

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1997.tb48385.x

    2. Microvascular Responses to Cerebral Ischemia/Inflammation (pages 132–147)

      GREGORY J. del ZOPPO

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1997.tb48386.x

    3. Enhancement of Apoptosis in Cerebral Endothelial Cells by Selected Inflammatory Signals (pages 148–153)

      CHUNG Y. HSU, ARIF SHAIKH, CHEN-HSIUNG YEH, LAURA L. DUGAN, TIEN-SUNG LIN and JIAN XU

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1997.tb48387.x

    4. Selected Poster Papers

    5. Possible Pathogenetic Role of Activated Platelets in the Primary Antiphospholipid Syndrome Involving the Central Nervous System (pages 188–200)

      LORENZO EMMI, CARLO BERGAMINI, ALESSANDRO SPINELLI, FRANCESCO LIOTTA, TERESA MARCHIONE, ANNA CALDINI, ALESSANDRA FANELLI, MARIA TERESA DE CRISTOFARO and GIANFRANCO DAL POZZO

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1997.tb48391.x

  4. Part III. Neuroendocrine Aspects of Systemic Lupus Erythematosus

    1. Top of page
    2. Preface
    3. Part I. Stress, Stroke, and Seizures
    4. Part II. Cerebrovascular Disease in Systemic Lupus Erythematosus
    5. Part III. Neuroendocrine Aspects of Systemic Lupus Erythematosus
    6. Part IV. Autoantibodies and Systemic Lupus Erythematosus
    7. Part V. Planning Studies
    1. The Hypothalamic-Pituitary-Adrenal Axis in Autoimmunity (pages 214–224)

      M. S. HARBUZ, G. L. CONDE, O. MARTI, S. L. LIGHTMAN and D. S. JESSOP

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1997.tb48393.x

    2. Immune Modulation of the Hypothalamic-Pituitary-Adrenal Axis : Cytokines and Gases in the Hypothalamus (pages 225–233)

      ASHLEY GROSSMAN, ALFREDO COSTA, MARY FORSLING, RICHARD JACOBS, PIERLUIGI NAVARRA and MARIA SATTA

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1997.tb48394.x

    3. Central Interleukin-1 Receptors as Mediators of Sickness (pages 234–246)

      KEITH W. KELLEY, KEVIN HUTCHISON, RICHARD FRENCH, ROSE-MARIE BLUTHÉ, PATRICIA PARNET, RODNEY W. JOHNSON and ROBERT DANTZER

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1997.tb48395.x

    4. Selected Poster Paper

      Endocrine Correlates of Murine Systemic Lupus Erythematosus in the MRL lpr/lpr Model (pages 252–255)

      N. SHANKS, P. M. MOORE, P. PERKS and S. L. LIGHTMAN

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1997.tb48397.x

  5. Part IV. Autoantibodies and Systemic Lupus Erythematosus

    1. Top of page
    2. Preface
    3. Part I. Stress, Stroke, and Seizures
    4. Part II. Cerebrovascular Disease in Systemic Lupus Erythematosus
    5. Part III. Neuroendocrine Aspects of Systemic Lupus Erythematosus
    6. Part IV. Autoantibodies and Systemic Lupus Erythematosus
    7. Part V. Planning Studies
    1. Autoantibodies: Markers of Disease or Pathogenic? (pages 256–262)

      DAVID A. ISENBERG

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1997.tb48398.x

    2. Anti-P Antibodies and Neuropsychiatric Lupus Erythematosus (pages 263–269)

      LIVIU GEORGESCU, DROR MEVORACH, FRANK C. ARNETT, JOHN D. REVEILLE and KEITH B. ELKON

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1997.tb48399.x

    3. Antiphospholipid Antibodies and Cerebral Lupus (pages 270–278)

      E. NIGEL HARRIS and SILVIA PIERANGELI

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1997.tb48400.x

    4. Antiphospholipid Antibodies and the Antiphospholipid Syndrome : Clinical Relevance in Neuropsychiatric Systemic Lupus Erythematosus (pages 279–288)

      DONATO ALARCÓN-SEGOVIA, BRUNO ESTAÑOL, GUILLERMO GARCÍA-RAMOS and ANTONIO R. VILLA

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1997.tb48401.x

    5. Serum Antibodies to Gangliosides in Systemic Lupus Erythematosus (pages 300–302)

      A. NEISSER, B. GATTERBAUER, W. GRANINGER, M. MENSCHIK and H. BERNHEIMER

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1997.tb48403.x

    6. Selected Poster Papers

      Inhibition of Sodium Channel Currents by Antineuronal Autoantibody from Autoimmune Mice (pages 303–307)

      J. CRIMANDO, K. COOPER and S. A. HOFFMAN

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1997.tb48404.x

  6. Part V. Planning Studies

    1. Top of page
    2. Preface
    3. Part I. Stress, Stroke, and Seizures
    4. Part II. Cerebrovascular Disease in Systemic Lupus Erythematosus
    5. Part III. Neuroendocrine Aspects of Systemic Lupus Erythematosus
    6. Part IV. Autoantibodies and Systemic Lupus Erythematosus
    7. Part V. Planning Studies
    1. Strategies in Selecting an Agent for Clinical Trials (pages 319–327)

      RICHARD W. PECK

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1997.tb48406.x

    2. Summary : Highlights and Future Directions (pages 328–333)

      PATRICIA M. MOORE

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1997.tb48407.x

SEARCH

SEARCH BY CITATION